ورم الدماغ

إعداد فريق مايو كلينك
07 أكتوبر 2026

الأبحاث

المنشورات

راجع قائمة المنشورات التي أعدّها أطباء مايو كلينك حول أورام الدماغ على محرك البحث PubMed، وهو خدمة تقدمها المكتبة الوطنية الأمريكية للطب.

  1. Niederhuber JE, et al., eds. Cancer of the central nervous system. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Sept. 27, 2022.
  2. Adult central nervous system tumors treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/brain/patient/adult-brain-treatment-pdq. Accessed Sept. 27, 2022.
  3. Bouzinab K, et al. In search of effective therapies to overcome resistance to Temozolomide in brain tumours. Cancer Drug Resistance. 2019; doi:10.20517/cdr.2019.64.
  4. Louis DN, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: A summary. Neuro-Oncology. 2021; doi:10.1093/neuonc/noab106.
  5. Chheda MG, et al. Uncommon brain tumors. https://www.uptodate.com/contents/search. Accessed Nov. 10, 2022.
  6. Childhood medulloblastoma and other central nervous system embryonal tumors treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/brain/patient/child-cns-embryonal-treatment-pdq. Accessed Nov. 15, 2022.
  7. Childhood central nervous system germ cell tumors treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/brain/patient/child-cns-germ-cell-treatment-pdq. Accessed Nov. 15, 2022.
  8. Ostrom QT, et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019. Neuro-Oncology. 2022; doi:10.1093/neuonc/noac202.
  9. Winn HR, ed. Youmans and Winn Neurological Surgery. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Sept. 27, 2022.
  10. Wong ET, et al. Overview of the clinical features and diagnosis of brain tumors in adults. https://www.uptodate.com/contents/search. Accessed Sept. 27, 2022.
  11. Edlow JA, et al. Medical and nonstroke neurological causes of acute, continuous vestibular symptoms. Neurology Clinics. 2015; doi:10.1016/j.ncl.2015.04.002.
  12. Cellphones and cancer risk. National Cancer Institute. https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/cell-phones-fact-sheet. Accessed Oct. 21, 2022.
  13. Central nervous system cancers. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1425. Oct. 28, 2022.
  14. Stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). RadiologyInfo.org. https://www.radiologyinfo.org/en/info/stereotactic. Nov. 4, 2022.
  15. Distress management. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1431. Accessed Sept. 27, 2022.
  16. Muthupillai R, et al. Magnetic resonance elastography. Nature Medicine. 1996; doi:10.1038/nm0596-601.
  17. Murphy MC, et al. MR elastography of the brain and its application in neurological diseases. NeuroImage. 2019. doi:10.1016/j.neuroimage.2017.10.008.
  18. Warner KJ. Allscripts EPSi. Mayo Clinic. Jan. 7, 2021.
  19. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed Nov. 30, 2022.
  20. Genetic/familial high-risk assessment: Breast, ovarian and pancreatic. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1503. Accessed Nov. 30, 2022.
  21. AskMayoExpert. Lynch syndrome management. Mayo Clinic; 2021.
  22. Hügel M, et al. Long-term survival in patients with brain metastases — Clinical characterization of a rare scenario. Strahlentherapie und Onkologie. 2024; doi:10.1007/s00066-023-02123-4.
  23. AlTamimi JO, et al. Brain Metastases in Adults: A Five-Year Observational Study From King Abdulaziz Medical City. Cureus Journal of Medical Science. 2022; doi:10.7759/cureus.31197.
  24. Winther RR, et al. Survival, quality of life, and motor function in brain metastases surgery: The role of complete resection. Neuro-Oncology Practice. 2025; doi:10.1093/nop/npaf011.
  25. Zhou X, et al. Clinical significance of various classification standards of age groups in predicting survival of patients with glioblastoma. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2020; doi:10.12659/MSM.920627.
  26. Al Sharie S, et al. Decoding diffuse midline gliomas: A comprehensive review of pathogenesis, diagnosis and treatment. Cancers. 2023; doi:10.3390/cancers15194869.
  27. Yashin K, et al. OCT-Guided Surgery for Gliomas: Current Concept and Future Perspectives. Diagnostics. 2022; doi:10.3390/diagnostics12020335.
  28. Garnier L, et al. Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study. The Oncologist. 2022; doi:10.1093/oncolo/oyac023.
  29. Anand L, et al. Development of Machine Learning and Medical Enabled Multimodal for Segmentation and Classification of Brain Tumor Using MRI Images. Computational Intelligence and Neuroscience. 2022; doi:10.1155/2022/7797094.
  30. Barbaro M, et al. Causes of Death and End-of-Life Care in Patients With Intracranial High-Grade Gliomas: A Retrospective Observational Study. Neurology. 2022; doi:10.1212/WNL.0000000000013057.
  31. Gue R, et al. The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas. Biomedicines. 2024; doi:10.3390/biomedicines12061349.